EUVIMEDAvasta EUVIMED
Crossref

A microbial metabolite reframes the gut–kidney axis in calcium oxalate nephropathy †

Khalid A Abdelhalim

The Journal of Pathology · 2026-11-19

DOI: 10.1002/path.70158 ↗

At a glance

Journal article in The Journal of Pathology, published online on 2026-11-19. Written by Khalid A Abdelhalim. 15 references.

AbstraktBibliograafilised andmedCiteRelated studies

Abstract (original language)

Kidney stone disease has long been viewed primarily as a disorder of urinary supersaturation, with therapeutic strategies focusing on reducing urinary oxalate and preventing crystal formation. Increasing evidence, however, suggests that renal epithelial injury, immune responses, and the gut microbiota are integral components of disease pathogenesis. In their recent article, published in The Journal of Pathology , Li, Chen, Lin, Jian et al provide compelling evidence that microbiota‐derived tryptophan metabolism constitutes an important regulator of calcium oxalate nephropathy. Through integrated metagenomic and metabolomic analyses of patients with calcium oxalate stones, followed by mechanistic validation in experimental models, the authors identify indole‐3‐propionic acid (IPA) as a key microbial metabolite depleted in stone formers. They further demonstrate that IPA protects against renal crystal deposition by activating aryl hydrocarbon receptor (AhR) signaling, inducing suppressor of cytokine signaling 3 (SOCS3), suppressing STAT1 activation, and ultimately limiting tubular epithelial apoptosis. Beyond identifying a candidate therapeutic metabolite, this study shifts the current paradigm from considering the gut microbiota solely as a regulator of intestinal oxalate metabolism to recognizing microbial metabolites as active mediators of renal injury and repair. These findings broaden our understanding of the gut–kidney axis and provide a framework for developing microbiome‐based therapeutic strategies targeting host signaling pathways in nephrolithiasis. © 2026 The Pathological Society of Great Britain and Ireland.

Cite

APA

Abdelhalim, K. A. (2026). A microbial metabolite reframes the gut–kidney axis in calcium oxalate nephropathy †. The Journal of Pathology. https://doi.org/10.1002/path.70158

Vancouver

Abdelhalim KA. A microbial metabolite reframes the gut–kidney axis in calcium oxalate nephropathy †. The Journal of Pathology. 2026. doi:10.1002/path.70158

BibTeX
@article{Abdelhalim2026,
  author = {Abdelhalim, Khalid A},
  title = {A microbial metabolite reframes the gut–kidney axis in calcium oxalate nephropathy †},
  journal = {The Journal of Pathology},
  year = {2026},
  doi = {10.1002/path.70158}
}
Start for free →